Arena Investors: Moment of Truth

Before you go, we thought you'd like these...
Before you go close icon

Arena Pharmaceuticals investors, it has been a wild ride. Shares may be down 15% today from profit taking, but this stock is still a six-bagger year to date. However, June 27 looms large, as investors could be handsomely rewarded or left picking up the pieces. Find out why, and what health care editor David Williamson is urging investors to do.

A better approach
Health care investors are always looking for the next big breakthrough, and Motley Fool co-founder David Gardner recently identified a small-cap health care company poised for monster returns. To uncover this top pick today, enjoy the special free report: "Discover the Next Rule-Breaking Multibagger." Don't miss out on this limited-time offer and your opportunity to discover this game-changing company before the market does. Click here to access your report -- it's totally free.

The article Arena Investors: Moment of Truth originally appeared on Fool.com.

David Williamsonholds no position in any company mentioned. Click here to see his holdings and a short bio. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners